Source: BioPortfolio

Kidney Cure: Israeli cell therapy co KidneyCure raises $4m

The Tel Aviv based company develops treatment in which a "minikidney" produced from the patient's cells supports the activity of the diseased kidney.

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Alon Yaar's photo - CEO of KidneyCure

CEO

Alon Yaar

CEO Approval Rating

82/100

Read more